[ad_1] EDINBURGH, Scotland, Dec. 11, 2025 /PRNewswire/ — Wobble Genomics, a biotechnology company focused on improving cancer outcomes through better diagnosis and therapy selection, will present new data at the 2025 San Antonio Breast Cancer […]
Tag: Biotechnology
Pillar Biosciences and AstraZeneca Expand Liquid Biopsy Access Partnership to China
[ad_1] NATICK, Mass., Dec. 8, 2025 /PRNewswire/ — Pillar Biosciences announced today an expansion of its existing laboratory access program with AstraZeneca for NGS-based kitted liquid biopsy tumor profiling to include China. This expanded collaboration […]
Lee’s Pharmaceutical Holdings Limited acquiert la plateforme et les actifs de Staccato® One Breath Technology®, renforçant ainsi l’expansion de son pipeline et faisant progresser son partenariat mondial avec UCB grâce aux droits acquis USA – Français APAC – English APAC – Traditional Chinese USA – English Japan – Japanese Korea – 한국어 USA – English USA – Deutsch USA – español
[ad_1] Acquisition de Staccato® One Breath Technology®, une plateforme technologique brevetée au vaste potentiel thérapeutique Synergie et complémentarité avec le portefeuille de produits existants de Lee’s Pharm, et Acquisition des droits de licence et de fabrication […]
Lee’s Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights USA – English APAC – English APAC – Traditional Chinese USA – English Japan – Japanese Korea – 한국어 USA – Français USA – Deutsch USA – español
[ad_1] Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential Synergistic and complementary to Lee’s Pharm’s existing products pipeline, and Acquisition of rights as licensor and manufacturer of Staccato® alprazolam under a […]
Lee’s Pharmaceutical Holdings Limited erwirbt Staccato® One Breath Technology® Plattform und Vermögenswerte, um seine Pipeline zu erweitern und die globale Partnerschaft mit UCB durch die erworbenen Rechte voranzutreiben USA – Deutsch APAC – English APAC – Traditional Chinese USA – English Japan – Japanese Korea – 한국어 USA – English USA – Français USA – español
[ad_1] Erwerb der Staccato® One Breath Technology®, einer proprietären Plattformtechnologie mit breitem therapeutischen Potenzial Synergistisch und komplementär zur bestehenden Produktpipeline von Lee’s Pharm Erwerb der Rechte als Lizenzgeber und Hersteller von Alprazolam Staccato® im Rahmen einer globalen […]
